The Contribution of Malglycemia to Mortality among Allogeneic Hematopoietic Cell Transplant Recipients
Open Access
- 31 March 2009
- journal article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 15 (3), 344-351
- https://doi.org/10.1016/j.bbmt.2008.12.488
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantationBlood, 2008
- Hyperglycemia During the Neutropenic Period Is Associated With a Poor Outcome in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell TransplantationTransplantation, 2007
- Clinical experience with tight glucose control by intensive insulin therapyCritical Care Medicine, 2007
- Tight blood glucose control: What is the evidence?Critical Care Medicine, 2007
- Intensive Insulin Therapy in the Medical ICUThe New England Journal of Medicine, 2006
- Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteersBritish Journal of Clinical Pharmacology, 2005
- Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityEuropean Heart Journal, 2005
- Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult PatientsMayo Clinic Proceedings, 2004
- A disturbed glucose metabolic state (dysglycaemia) is a key risk factor for cardiovascular eventsEuropean Heart Journal Supplements, 2003
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982